Comparison of cast-associated pruritus prevention using calamine lotion and talcum powder: A randomized trial

Main Article Content

Boontangjai C, MD
Tangtrakulwanich B, MD, Ph.D

Abstract

Objective: To compare the efficacy between calamine lotion and talcum powder in reducing pruritus in patients having distal radius fractures treated with short arm casts.


Materials and methods: Patients having a closed distal radius fracture without associated injuries aged 15-80 years visiting our emergency unit were randomized into talcum powder and calamine groups. All patients were treated by closed reduction and a short arm cast for four weeks. Atarax and paracetamol were prescribed for rescue medication. Patients were requested to report their pruritus score (0-10) daily in a supplied diary. The patients were followed up at one week for cast changing and then every week until cast removal. After cast removal, the skin condition was inspected for skin problems and the patients rated their satisfaction with the overall treatment.


Result: Thirty-four patients with distal radius fractures were randomized into talcum powder (19) and calamine (15) groups. The most common causes of fracture were fall and motor vehicle accident. No patient was lost to follow-up during the study period. Patients in the calamine group reported a significantly lower mean pruritus scores than those in the talcum powder group at the end of treatment period. There were no significant differences in the mean usage of rescue medication, complications, and satisfaction with treatment between the two groups.


Conclusion: Calamine lotion showed a better efficacy in reducing pruritus associated with casts than talcum powder in patients having distal radius fracture treated with short arm cast.

Article Details

Section
Original Articles

References

1. Fernandez DL, Wolf SW. Distal radius fractures. Green Operative Hand Surgery, 5th ed. Philadelphia. 2005: 645-661.
2. Scott H, Micheal B. Early soft tissue complication after fracture distal part of radius. J Bone Joint Surg [Am]. 1993; 75: 144-153.
3. Dion M. A prospective evaluation of patient experiences and skin condition during and after cast immobilization. J Nat Ortho Tech. 2002: 1-4.
4. Wong A, Watson B. Allergic contact dermatitis due to benzalkonium chloride in plaster of Paris. Aus J Dermatol. 2001; 42: 33-35.
5. Schmelz M. A neural pathway for itch. Nat Neurosci. 2001; 4: 9-10.
6. Davies MG, Greaves MW. Sensory responses of human skin to synthetic histamine analogues and histamine. Br J Clin Pharmacol. 1980; 9: 461-465.
7. Greavas MW. Antihistamine. Dermato Clin. 2001; 19: 53-62.
8. Krause L, Shuster S. Mechanism of action of antipruritus drugs. Br Med J. 1983; 287: 1199-1200.
9. Jeffery D, Bernhard JD. Itch and pruritus: what are they and how should itches be classified?. Dermato Ther. 2005; 18: 288-291.
10. Bromm B, Scharein F, Darsow U, Ring J. Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett. 1995; 187: 157-160.
11. Yosipovitch G, Szolar C, Hui XY, Maibach H. Effect of tropically applied menthol on thermal pain and itch sensations and biophysical properties of the skin. Arch Dermatol Res. 1996; 288: 245-248.
12. Staniforth P. Allergy to benzalkonium chloride in plaster of Paris after sensitization to cetrimide. J Bone Joint Surg [Am]. 1980; 62: 42:44.
13. Sawai J. Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. J Microbio Methods. 2003; 54: 177-182.
14. Misery L. Randomized controlled trial of a calamine-containing gel versus excipient in the treatment of idiopathic anal pruritus. Neuro Dermatol. 2004; 23: 7-9.